Engel A - Search Results

1

Routine Early 68Ga-DOTATATE Positron Emission Tomography Has Low Yield After Resection of Appendiceal Neuroendocrine Neoplasms.

Chan DL, Hoang J, Roach PJ, Arena J, Bailey DL, Nevell D, Pavlakis N, Engel A, Bernard EJ. Chan DL, et al. Among authors: engel a. Pancreas. 2020 Aug;49(7):891-896. doi: 10.1097/MPA.0000000000001589. Pancreas. 2020. PMID: 32658069

2

The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.

Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ. Chan JC, et al. Among authors: engel a. Ann Surg. 2017 Mar;265(3):539-546. doi: 10.1097/SLA.0000000000001743. Ann Surg. 2017. PMID: 27070934 Free PMC article.

3

A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.

Chan JCY, Diakos CI, Chan DLH, Engel A, Pavlakis N, Gill A, Clarke SJ. Chan JCY, et al. Among authors: engel a. Ann Surg. 2018 Jun;267(6):1119-1125. doi: 10.1097/SLA.0000000000002251. Ann Surg. 2018. PMID: 28394869

4

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.

Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, Barnes T, Diakos C, Khasraw M, Samra J, Eslick E, Roach PJ, Engel A, Clarke SJ, Bailey DL. Chan DL, et al. Among authors: engel a. Theranostics. 2017 Mar 1;7(5):1149-1158. doi: 10.7150/thno.18068. eCollection 2017. Theranostics. 2017. PMID: 28435454 Free PMC article.

5

Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study.

Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill A, Clarke SJ. Chan JCY, et al. Among authors: engel a. PLoS One. 2019 Jun 12;14(6):e0218207. doi: 10.1371/journal.pone.0218207. eCollection 2019. PLoS One. 2019. PMID: 31188892 Free PMC article.

6

Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.

Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill A, Clarke SJ. Chan JCY, et al. Among authors: engel a. PLoS One. 2020 Jan 30;15(1):e0228466. doi: 10.1371/journal.pone.0228466. eCollection 2020. PLoS One. 2020. PMID: 31999779 Free PMC article.

7

Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).

Chan DL, Clarke SJ, Engel A, Diakos CI, Pavlakis N, Roach PJ, Bailey DL, Bauer J, Findlay M. Chan DL, et al. Among authors: engel a. Eur J Clin Nutr. 2022 Jan;76(1):143-149. doi: 10.1038/s41430-021-00915-4. Epub 2021 May 13. Eur J Clin Nutr. 2022. PMID: 33986486

8

Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.

Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill A, Clarke SJ. Chan JCY, et al. Among authors: engel a. PLoS One. 2021 Aug 5;16(8):e0244898. doi: 10.1371/journal.pone.0244898. eCollection 2021. PLoS One. 2021. PMID: 34351923 Free PMC article.

9

Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.

Gordon S, Chan DLH, Bernard EJ, Eslick ME, Willowson KP, Roach PJ, Engel AF, Maher R, Clarke SJ, Agarwal V, Yasmin L, De Silva M, Mascall S, Conner A, Nevell D, Pavlakis N, Bailey DL. Gordon S, et al. Among authors: engel af. J Cancer Res Clin Oncol. 2023 Aug;149(10):7717-7728. doi: 10.1007/s00432-023-04706-1. Epub 2023 Apr 1. J Cancer Res Clin Oncol. 2023. PMID: 37004598 Free PMC article.

10

CD11c⁺ and IRF8⁺ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy.

Tse BCY, Bergamin S, Steffen P, Hruby G, Pavlakis N, Clarke SJ, Evans J, Engel A, Kneebone A, Molloy MP. Tse BCY, et al. Among authors: engel a. Oncoimmunology. 2023 Jul 20;12(1):2238506. doi: 10.1080/2162402X.2023.2238506. eCollection 2023. Oncoimmunology. 2023. PMID: 37485033 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,941 results

Search Page